Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the trea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results